This strain was able to elevate the number of OVA-specific CD8 + T cells in vivo, and the mice inoculated with CHA-OST S54-Ova were resistant to the challenge of OVA-expressing mouse melanoma cell line B16 (Epaulard et al, 2006). The gene discussed is CD8A; the disease is melanoma.